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Pulmonary and Percutaneous Absorption
of 2-Propoxyethyl Acetate and 2-Ethoxyethyl
Acetate in Beagle Dogs
by Derek Guest,*t Marva L. Hamilton,* Peter J. Deisinger*
and George D. DiVincenzo*
A comparison was made of the absorption and elimination rates of 2-propoxyethyl acetate (PEA) and
2-ethoxyethyl acetate (EEA) following inhalation, dermal application or IV administration. Male beagle
dogs were exposed to 50 ppm PEA or EEA for 5 hr, and breath samples were collected during the exposure
and a 3-hr recovery period. Both compounds were rapidly absorbed through the lungs. After 10 min of
exposure, the concentrations of the parent compounds in the expired breath were 5 to 10 ppm (80-90%
absorption) and reached plateau values at about 3 hr of 13 ppm for PEA (74% absorption) and 16 ppm for
EEA (68% absorption). Post-exposure breath samples declined exponentially to 0.5 ppm and 2 ppm after 3
hr for PEA and EEA, respectively. Expired concentrations of PEA were slightly, but significantly (p <
0.025), lower than those of EEA at corresponding times during the exposure. After IV dosing with I mg/kg
[ethyl-1,2-'4C]PEA, the urine contained 61% and 88% ofthe dose in 4 and 24 hr, respectively. [14C]EEA was
eliminated more slowly, with 20% and 61% of the dose appearing in the urine in 4 and 24 hr, respectively.
Blood elimination half-lives were 1.6 hr for ['4C]PEA and 7.9 hr for['"C]EEA. Only trace amounts of"CO2
(< 1%) or volatile materials (< 0.1%) were detected in the expired air with either compound. For studies of
percutaneous absorption, [14CIPEA or [14C]EEA was added to undiluted compound and applied in a glass
cell to a shaved area on a dog's thorax for 30 or 60 min. Blood and expired air were collected for 8 hr and
urine for 24 hr. The pattern of urinary elimination for each compound was similar to that seen after IV
dosing, with [14C]PEAbeingexcreted morerapidly than [14C]EEA. Although the excretion rates forthe two
compounds were markedly different, the absorption rates were similar. Estimated over a 60-min period, the
percutaneous absorption rates were 116 and 110 nmole/cm2/min for PEA and EEA, respectively. These
values are similar to those for other lipid-soluble compounds. Taken together, these data may be
extrapolated to allow the estimation of PEA and EEA uptake in man.
Introduction
The ethylene glycol ethers have been used exten-
sively in industry and consumer products for a number
of years. They are highly miscible with water and
organic solvents and have found application in coatings,
dyes, insecticides, soaps and cosmetics. Exposure may
therefore occur both by skin contact and inhalation.
In general, this class of compounds exhibits low to
moderate toxicity and only slight skin irritation, even
though most are readily absorbed percutaneously (1).
Recent reports, however, have indicated that some
ethylene glycol ethers and their acetic acid esters
producereproductive effectsinlaboratory animals (2-5).
Both 2-ethoxyethanol and 2-ethoxyethyl acetate have
beenreported toproduce teratogenic effects and testicu-
lar changes in rodents (2,5,6). After repeated, high oral
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doses (2200-4400 mg/kg), 2-propoxyethyl acetate pro-
duced testicular atrophy in rats (7). 2-Propoxyethanol
administered orally for 6 weeks at approximately 1500
mg/kg did not produce reproductive effects in male rats
(2).
In view of these findings, a comparison was made of
the absorption and elimination rates oftwo glycol ether
derivatives, 2-propoxyethyl acetate and 2-ethoxyethyl
acetate, in dogs after inhalation, dermal application or
intravenous administration.
Materials and Methods
Materials
[Ethyl-112-14C]2-propoxyethyl acetate([14C]PEA)and
[ethyl-1,2- 4C]2-ethoxyethyl acetate ([14C]EEA) were
purchased from California Bionuclear Corporation (Sun
Valley, CA). The radiochemical purity ofeach compound
wasdeterminedbygaschromatography andradiochemi-
cal detection with a Gas Proportional Counter (ModelGUEST ET AL.
894, Packard Instrument Co., Downers Grove, IL).
Both isotopic materials were found to be greater than
98% radiochemically pure, each with a single radioac-
tive contaminant, probably the corresponding alcohol.
The specific radioactivity of the [14C]PEA was 40.0
pRCi/mg and that of the [14C]EEA was 17.4 ,uCi/mg.
Nonradioactive PEA (Eastman Chemical Products,
Kingsport, TN) and EEA (Kodak Laboratory Chemi-
cals, Rochester, NY) were assayedforpuritybyGC-MS;
PEA was greater than 98% pure and EEA was 95%
pure (major impurity ethylene diacetate).
Animals
Male beagle dogs weighing 10 to 13 kg were obtained
from Marshall Research Animals, Inc. (North Rose,
NY). Dogs used for skin application and intravenous
(IV) administration experiments were fasted for 16 hr
before use. A suitable area of skin on the dog's thorax
was shaved one day prior to a skin absorption
experiment. Atropine sulfate and Ace-Promazine were
administered as pre-anesthetics. Dogs were anesthe-
tized with sodium pentobarbital for the duration ofthe
experiment. Dogs used forinhalation experiments were
not fasted prior to use.
Methods
Inhalation Exposure. Inhalation exposures were
conducted at aconcentration of50 ppm with eitherPEA
(299 mg/m3) or EEA (270 mg/m3). Two animals, housed
in separate cages, were exposed in each experiment.
Four animals were exposed to each compound.
The exposure facility consisted of a 32,000 L interior
room, equipped with an independent, adjustable air
supply system. The exposure room was maintained at a
slight negative pressure. Filtered air was supplied to
the exposure facility at a rate of 10,000 L/min which
resulted in 19 air changes per hour.
The test substance was metered into a 5-L round-
bottomed flask by using a dual syringe pump (Modern
Metalcraft, Midland, MI). The flask was heated to
110°C, and the vaporized compound was flushed from
the flask with a stream of dried nitrogen (50 L/min).
The vapor was carried into the room air supply via 1/2
in. stainless steel tubing. The room concentration of
test compound was monitored continuously with a
Beckman Model 400 Hydrocarbon Analyzer (Beckman
Instruments, Inc., Fullerton, CA). The hydrocarbon
analyzer was calibrated with a 50 ppm standard ofeach
test compound. The time-weighted average exposure
concentrations, calculated from the output ofthe hydro-
carbon analyzer, were 50.3 + 1.6 ppm for PEA and
50.8 ± 1.1 ppm for EEA (x ± SD). A sample of
room air was collected during each exposure and
assayed by gas chromatography to verify the room
concentrations.
All sample handling systems used in these experi-
ments were fabricated of either Teflon, glass or stain-
less steel. Expired air samples were collected utilizing a
close-fitting mask fabricated from Teflon. The mask was
constructed with a sampling port connected to a length
of Teflon tubing, a breathing port, and a pressure
indicator. At sampling times, the mask was strapped to
the animal's head, and a 25-mL repeating dispenser
(Brinkmann Instruments, Westbury, NY) was con-
nected to the sampling port of the mask. A 750-mL
Teflon gas sampling bag was connected to the outlet of
the repeating dispenser. A breath sample was aspirated
from the mask on the upstroke of the dispenser and
dispensed into the gas samplingbag on the downstroke.
Pooled end tidal breath samples (approximately 30
breaths) were collected during the late phase of
exhalation.
A breath sample was collected from each dogbefore it
entered the inhalation chamber and after 10, 20, 40, 60,
90, 120, 180, 240 and 300 min of exposure. The dogs
were removed from the chamber and breath samples
were collected at 10, 20, 40, 60, 90, 120 and 180 min
after exposure.
Breath and room atmosphere samples were analyzed
on aVarian2100 gas chromatograph (Varian Instrument
Division, Palo Alto, CA) equipped with a flame ioniza-
tion detector. Gaseous samples were injected through a
25-mL sampling valve (Carle Instruments, Inc.). Gas
chromatographic separation was achieved on a 6-ft glass
column packed with 20% Carbowax 20M on 80/100
Gas-Chrom Q at 75°C. For quantitation, sample peak
areas were compared to those of external standards.
The standards were prepared by vaporizing a measured
volume of test compound with air metered through a
Singer No. 802 Flowmeter (Singer, American Meter
Division) into a Teflon gas sampling bag.
Statistical evaluation of the data was accomplished
with a program developed by the Statistical Analysis
System Institute (8).
Intravenous Administration. For intravenous ad-
ministration experiments, the radioactive compound
was added to a solution ofthe nonradioactive compound
in saline to give a final concentration of 5 to 10 mg/mL.
Approximately 3 mL of this solution (containing about
10 ,uCi) was administered via an in-dwelling forelimb
intravenous catheter at a dose level of 1 mg/kg body
weight.
Expired air was collected continuously into a Teflon
bag by means of an endotracheal tube connected to a
two-way valve and passed through silica gel and sodium
hydroxide traps to absorb expired volatile organic
materials and carbon dioxide, respectively.
Blood samples were collected in heparinized tubes at
intervals up to 8 hr. A continuous saline drip was
maintained throughout the experiment to replace lost
body fluids. Urine samples were collected at 4 and 8 hr
by means ofa urethral catheter. Overnight urines (8-24
hr) were collected from conscious dogs housed after
recovery in stainless steel metabolism cages.
A Packard Tri-Carb scintillation spectrometer (Model
2660, Packard Instruments, Downers Grove, IL) was
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used for the determination ofradioactivity. Radioactive
samples were dissolved in Eastman Ready-to-Use II
scintillation fluid (Eastman Kodak Company, Rochester,
NY). A Packard sample oxidizer (Model 306) was used
for the measurement of radioactivity in blood samples.
SkinExposure. Fordermalapplication anappropri-
ate quantity of radioactively labeled compound was
added to 25 mL ofundiluted nonlabeled compound and a
portion (40 ,uCi, 15 mL) was transferred to a sealed,
glass absorption cell secured to the dog's thorax with
surgical tape and adhesive (Skin Bond, Howmedica
Inc., Largo, FL). Cotton gauze inside the cell facilitated
a uniform distribution of the solution. The absorption
cell measured 15 cm long, 3 to 4 cm wide and 1.5 cm
deep with a skin contact surface area of 55.6 cm2.
Exposures were carried out for 30 or 60 minutes.
Expired air, blood and urine samples were collected
and analyzed as described above. Absorption rates were
calculated after correction for incomplete excretion of
material using the data obtained from IV experiments.
In Vitro Percutaneous Absorption
Whole skin was removed from the thorax of beagle
dogs at necropsy, and kept moist with saline under
refrigeration until used. Subcutaneous fat was removed
and sections (approximately 1.5 cm diameter) cut to fit
across a glass diffusion cell (Franz diffusion cell, Crown
Glass Co., Somerville, NJ). The skin contact area was
0.9 cm2. The lower chamber of the cell was filled with
isotonic saline maintained at 37°C. The absorption rates
oflt14C]PEA and [14C]EEA were determined by placing
an excess of compound (0.3 mL, 1.5 puCi) in the upper
chamber ofthe cell and measuring its appearance in the
lower chamber hourly from 2 to 7 hr.
The values obtained at each time point were cor-
rected for loss of material due to sampling. Six to eight
cells were run for each compound using skin from each
of two dogs. The absorption rates were calculated by
linearregression analysis ofthe data from the time that
steady state absorption was obtained.
An estimate of the integrity of the skin sample in
each cell before and after exposure to [14C]PEA or
[14C]EEA was obtained by determination ofthe perme-
ability of the preparation to tritiated water. These
measurements also provided an indication ofthe poten-
tial ofeach compound to cause irreversible,skin damage
that would lead to an increase in permeability. The
damage ratio was calculated as the ratio ofthe tritiated
water permeability after skin contact with the glycol
ether to the initial tritiated water permeability.
Results
Inhalation Exposures
Analysis ofthe end tidal air samples during exposure
to 50 ppm of PEA or EEA indicated that both com-
pounds were rapidly absorbed through the lungs. The
breath concentrations ofPEA and EEA showed a rapid
increase with the duration of exposure and reached a
plateau after about 3 hr. After 10 min of exposure to
PEA, 5 ppm PEA was detected in the end tidal air,
indicating that 90% ofthe inhaled vapor was absorbed.
PEA concentrations in breath reached a plateau at
about 13 ppm which indicated that 74% of the inhaled
PEA was absorbed. After 10 min exposure to EEA, 9
ppm EEA was detected in the breath (ca. 80%
absorption). The EEA concentration reached a plateau
at about 16 ppm, indicating that 68% of the inhaled
compound was absorbed.
Post-exposure breath samples showed a rapid, expo-
nentialdecline forboth compounds. At 10 min, the PEA
breath concentration was 5 ppmand declined to 0.5 ppm
at 3 hr post-exposure. The breath concentration of
EEA was 7 ppm at 10 min and decreased to 2 ppm at 3
hr post-exposure.
The serial expired air PEA concentrations were
consistently lower than the EEA concentrations at
corresponding times during and after the exposure
(Fig. 1). Thesefindingswerestatistically significant (p <
0.025) during the exposure. Linear regression analysis
ofthe curves duringthe exposures showed no significant
differences in the slopes, indicating that there was a
similar rate of equilibration in the lungs for these two
compounds.
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FIGURE 1. Exposure (a) and post-exposure (b) serial expired air
concentrationsof(A)2-propoxyethylacetateand(0)2-ethoxyethyl
acetate in male beagle dogs. Exposure concentrations were 50
ppm for each compound. The results are expressed as the means
from four dogs.
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Table 1. Excretion of radioactivity by dogs following intravenous administration of ["C]PEA or [14C]EEA.a
% of administered dose at various collection periodsb('
0-4 hr 4-8 hr 8-24 hr Total (0-24 hr)
[14C]PEA
Urine 61.2 + 2.9 17.3 ± 0.8 8.0 (7.7, 8.2) 88.6 (87.7, 89.4)
Carbon dioxide 0.8 ± 0.1 0.6 ± 0.1 e
Volatile organics ( (e
[14C]EEA
Urine 19.6 + 7.0 18.6 ± 4.4 22.8 ± 2.5 61.1 + 2.3
Carbon dioxide 0.7 ± 0.1 0.9 ± 0.1
Volatile organics ((
aMale beagle dogs were anesthetized for the 8-hr duration of the experiment. [r4C1PEA ([ethyl-1,2- `4C]2-propoxyethyl acetate) or
[14C]EEA ([ethyl-1,2-14C]2-ethoxyethyl acetate) dissolved in saline (3 mL) was administered as a single dose of 1 mg/kg (10 ,uCi).
bThree dogs per group; mean + SE except where only two values determined.
cUrine and expired air collected under anesthesia for 8 hr using a urinary catheter and endotracheal tube, respectively. Dogs were conscious
and housed in metabolism cages for 8-24 hr urine collection.
dNo radioactivity detected (or < 0.1% of dose).
'Not measured.
There was no GC evidence for the presence ofvolatile
metabolites of either PEA or EEA in the expired air.
Intravenous Administration
After intravenous (IV) administration of [14C]PEA
(1 mg/kg), dogs eliminated about 88% ofthe radioactiv-
ity in the urine within 24 hr. The majority ofthis (61% of
the dose) was eliminated in the first 4 hr (Table 1, Fig.
2).
After IV administration of[14C]EEA (1 mg/kg) about
61% of the radioactivity was excreted in the urine
within 24 hr. Only approximately 20% of the dose was
eliminated in the first 4-hr period (Thble 1, Fig. 2).
The blood concentrations of radioactivity (expressed
asnmoleequiv./mL)afterIVadministrationof[14C]PEA
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FIGURE 2. Urinary elimination ofradioactivity in male beagle dogs
following IV administration of (0) [ethyl-1,2-14C]2-propoxyethyl
acetate ([14C]PEA) or (@) [ethyl-1,2-'4C]2-ethoxyethyl acetate
([14C]EEA) (1 mg/kg). See Table 1 for experimental details.
or [14C]EEA are shown in Figure 3. A marked differ-
ence was observed between the blood clearance rates
for PEA and EEA. After an initial, rapid distribution
phase lasting approximately 30 min, the radioactivity
from [14C]EEA declined exponentially throughout the
blood collection period, with an elimination half-life of
7.9 hr. The blood radioactivity after [14C]PEA admini-
stration was cleared more rapidly. The elimination
301
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FIGURE 3. Blood concentrations ofradioactivity in male beagle dogs
following intravenous administration of (0) [ethyl-1,2-14C]2-pro-
poxyethyl acetate ([14C]PEA) or (O) [ethyl-1,2-14C]2-ethoxyethyl
acetate ([14C]EEA (1 mg/kg). Points represent the means of
triplicate determinations in each of three dogs.
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profile for [14C]PEA was more complex and revealed a
number of distinct phases with different half-lives.
Estimation of the initial rate of elimination gave a
half-life of 1.6 hr.
Smallamounts ofradioactivity(< 1%ofthedose) were
detected as 1'CO2 in the 4-hr and 8-hr collections from
dogs receiving either [14C]EEA or [14C]PEA (Table 1).
Trace amounts ofradioactivity (< 0.1% ofthe dose) were
expired as volatile organic materials from either
[14C]EEA or [14C]PEA (Table 1).
Skin Exposure
The rates ofpercutaneous absorption and the elimina-
tion of radioactivity following 30-min or 60-min skin
exposures to [14C]EEA (110.5 mmoles) or [14C]PEA
(97.9 mmoles) are summarized in Table 2. Radioactivity
was detected in the urine at 4, 8 and 24 hr after 30-min
and 60-min exposures to both compounds (Table 2).
After exposure to [14C]PEA, urinary excretion ofradio-
activity was greatest at 4 hr and declined rapidly during
the remaining collection period. After exposure to
[14C]EEA, urinary excretion of radioactivity was sim-
ilar in the first two collection periods and was still
substantial overnight (Table 2). These patterns of
urinary 14C excretion were similar to the respective
excretion patterns seen after IV administration. No
measurable concentrations of radioactivity were de-
tected in the blood of dogs exposed for 60 min to
[14C]PEA or [14C]EEA.
For each compound, the amounts absorbed were
similar after 30-min and 60-min exposures (Table 2).
Small amounts of14CO2 were detected in the expired air
after exposure to both compounds.
In Vitro Percutaneous Absorption
The absorption of [14C]PEA and [14C]EEA through
dog skin in vitro is shown in Figure 4. The lag times
(time taken to reach steady state absorption) were
calculated by extrapolation ofthe linear portion ofeach
plot to the ordinate (Fig. 4, broken lines). The values
obtained were 1.2 hr (PEA) and 1.6 hr (EEA). The
slopes of the absorption plots indicate rates of absorp-
tion of 292 nmole/cm2/min (2.3 mg/cm2/hr) and 167
nmole/cm2/min (1.5 mg/cm2/hr) for EEA and PEA,
respectively (Table 3). As judged by tritiated water
permeability determinations (damage ratios) neither
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FIGURE 4. Invitroabsorptionof(*)2-propoxyethyl acetateand(0)
2-ethoxyethyl acetate through skin from male beagle dogs. Points
represent means ofmultiple determinations fromeach oftwodogs.
Table 2. Percutaneous absorption and elimination in breath and urine of radioactivity by dogs exposed to ["CIPEA or [14CIJEEA.a
Exposure '4C in 8 hr Percutaneous
time, breath, Radioactivity in urine, ,±mole/equiv.b absorption rate,
Compound min p.mole/equiv. 0-4 hr 4-8 hr 8-24 hr Ibtal nmole-cm'/min'
[14C]PEA 30 d 152.3 71.4 39.6 263.3 179.2
(179.7, 124.9) (91.4, 51.4) (59.9, 19.2) (331.0, 195.5)
60 5.7 ± 0.6 210.4 ± 16.7 84.4 ± 9.1 40.3 343.9 116.4
(52.5, 28.0) (339.4, 348.3)
[14C]EEA 30 d 60.2 59.2 105.7 225.1 219.3
(64.9, 55.5) (63.5, 54.9) (148.3, 63.1) (276.1, 173.4)
60 4.0 62.5 ± 4.4 70.9 ± 15.6 91.7 ± 21.5 225.0 ± 40.8 109.6
(5.8, 2.2)
a[Ethyl-1,2-14C]2-propoxyethyl acetate or [ethyl-1,214Cj2-ethoxyethyl acetate (15 mL) applied in 55.6 cm2 skin absorption cell, approx-
imately 40 ,uCi per experiment.
bValues presented are mean ± SE (where n = 3) or average (individual values) (where n = 2).
'Calculated after correcting for appropriate % excretion after IV administration (Table 1).
dNot collected.
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Table 3. In vitro absorption of ["4C]PEA or ['4C]EEA
through dog skin.
Absorption rate, Damage
Compound nmole/cm2/mina ratiob
PEA 163.0 ± 15.2 1.4 + 0.2
EEA 279.7 ± 33.6 1.3 ± 0.1
Controlc 1.4 ± 0.2
an = 9.
bSee methods for explanation (n = 8 or 9).
cWater applied to skin instead of glycol ether.
Table 4. Estimation of PEA or EEA uptake in man
(from in vivo dog absorption studies).
Estimated
uptake, mg
Route of Exposure
exposure time, hr PEA EEA
Inhalation (50 ppm)a 1.0 270 220
Skin (hands)b 0.5-1.0 580-760 640-645
al.25 m3 inhaled per hr, absorption 74% (PEA) or 68% (EEA).
b175 cm human, surface area 1.85 m2; hands comprise 4% surface
area.
EEA nor PEA altered the diffusion properties of the
skin preparations (Table 3).
Discussion
The inhalation studies demonstrate that PEA and
EEA are rapidly absorbed through the lungs. At
equilibrium (about 3 hr) about 70% ofthe inhaled vapor
was absorbed bythe dogs. Both compounds appeared to
be removed quickly from the blood, as indicated by the
rapid decline in the post-exposure breath concentra-
tions (Fig. 1). That the expired PEA concentrations
were significantly lower than the EEA concentrations
during the exposure may be a reflection of the more
rapid blood clearance and urinary excretion rates for
PEA (Tables 1 and 2; Figs. 2 and 3).
Blood concentrations of '4C after IV administration
showed different clearance rates for [14C]PEA and
[14C]EEA, with elimination half-lives of 1.6 hr and 7.9
hr, respectively (Fig. 3). These differences were
reflected in the urinary excretion rates, where 14C from
[14C]PEA was excreted more rapidly than that from
[14C]EEA (Table 1 and Fig. 2). Similarly, after skin
exposure, the urinary excretion rate for [14C]PEA was
greater than that for [14C]EEA, even though the total
amounts of each compound absorbed were comparable
(Table 2).
The different elimination characteristics of PEA and
EEA may result from differences in the metabolism of
the compounds. At present, no data are available on the
metabolism of PEA. Ethoxyacetic acid and N-ethoxy-
acetylglycine have been identified as metabolites of
ethoxyethanol in rats after inhalation and oral
administration. The combined excretion of the two
metabolites was estimated to be 30% of the oral doses
(9). Other ethylene glycol ethers, methoxyethanol,
butoxyethanol and 2-(2-ethoxyethoxy)ethanol, have also
been shown to be metabolized by oxidation to the
correspondingalkoxyacetic acid (10-12). Dealkylation of
[1-14C-ethoxy]2-ethoxyethanol has also been reported
(13). Thus it is reasonable to expect that PEA would
undergo the same metabolic reactions as these related
compounds. Different excretion rates for PEA and
EEA may therefore reflect quantitative differences in
metabolic products.
Although the excretion rates for PEA and EEA were
markedly different, the total amount ofeach compound
absorbed through the skin was similar (Table 2). The
fact that, for each compound, approximately equal
amounts ofradioactivity were absorbed in 30 and 60 min
may result from the relatively short exposure periods
used in these experiments. Percutaneous absorption
studies in vitro indicated absorption lag times of 1.2 hr
(PEA) and 1.6 hr (EEA) with dog skin before steady-
state absorption occurred, after which time EEA was
absorbed at a faster rate than PEA (2.3 mg/cm2/hr vs.
1.5 mg/cm2/hr) (Fig. 4 and Table 3).
The data from the in vivo dog experiments may be
used to estimate PEA or EEA uptake after human
exposure, assuming that the rate of absorption in man
is similar to that seen in dogs. Thus, after inhalation
exposure for 1 hr at a concentration of 50 ppm, about
270 mg of PEA or 220 mg of EEA would be absorbed
through the lungs. This is equivalent to about 2 g of
material in an 8-hr day. After immersion of both hands
for 30 to 60 min, about 580 to 750 mg ofPEA or 640 mg
of EEA would be absorbed through the skin. Extrapo-
lating from the clearance rates in dogs, the absorbed
PEA would be cleared more rapidly than EEA.
These absorption rates are similar to those obtained
in our laboratory for other lipid-soluble chemicals, such
as methyl n-butyl ketone and n-butanol (14,15).
The authors gratefully acknowledge the advice and assistance of
Dr. Edwin V Jeszenka, Ms. Barbara Terenzi and Mr. Robert G. Bo,
Toxicology Section, Health, Safety and Human Factors Laboratory.
REFERENCES
1. Rowe, V K., and Wolf, M. A. Derivatives of glycols. In: Patty's
Industrial Hygiene and Toxicology, 3rd Revised Ed., Vol. 2C
(G. D. Clayton and F. E. Clayton, Eds.), John Wiley and Sons,
New York, 1982, Chapt. 51.
2. Hardin, B. D., Bond, G. P, Sikov, M. R., Andrew, F. D., Beliles,
R. R, and Niemeier, R. W Testing of selected workplace
chemicals for teratogenic potential. Scand. J. Work Environ.
Health 7 (Suppl. 4): 66-75 (1981).
3. Miller, R. R., Ayres, J. A., Calhoun, L. L., Young, J. T., and
McKenna, M. J. Comparative short-term inhalation toxicity of
ethylene glycol monomethyl ether and propylene glycol mono-
methyl ether in rats and mice. Toxicol. Appl. Pharmacol. 61:
368-377 (1981).
4. Miller, R. R., Ayers, J. A., Young, J. T., and McKenna, M. J.
Ethylene glycol monomethyl ether: a subehronic inhalation study
in rats and rabbits. Toxicologist 2: 11 (40A) (1982).
5. Nagano, K., Nakayama, E., Oobayashi, H., Yamado, T., Adachi,
H., Nishizawa, T., Ozawa, H., Nakaichi, M., Okuda, H., Minami,ABSORPTION AND ELIMINATION OF PEA AND EEA 183
K., and Yamazaki, K. Embryotoxic effects of ethylene glycol
monomethyl ether in mice. Toxicology 20: 335-343 (1981).
6. Nelson, B. K., Setzer, J. V, Brightwell, W S., Mathinos, P R.,
Kuczuk, M. H., and Weaver, T. W Comparative inhalation
teratogenicity of four industrial glycol ether solvents in rats.
Teratology 25: 64A (1982).
7. Katz, G. V, Krasavage, W J., and Terhaar, C. J. Comparative
acute and subehronic toxicity ofethylene glycol monopropyl ether
and ethylene glycol monopropyl ether acetate. Environ. Health
Perspect. 57: 173-183 (1984).
8. SAS Institute. Statistical Analysis System (SAS), SAS User's
Guide. SAS Institute, Inc., Cary, NC, 1979.
9. Jonsson, A.-K., Pedersen, J., and Steen, G. Ethoxyacetic acid
and N-ethoxyacetylglycine: metabolites of ethoxyethanol (ethyl-
cellosolve) in rats. Acta Pharmacol. Toxicol. 50: 358-362 (1982).
10. Miller, R. R., Hermann, E. A., Langvardt, P W, McKenna, M.
J., and Schwetz, B. A. Comparative metabolism and dispostion of
ethylene glycol monomethyl ether and propylene glycol
monomethyl ether in male rats. Toxicol. Appl. Pharmacol. 67:
229-237 (1983).
11. Jonsson, A.-K., and Steen, G. n-Butoxyacetic acid, a urinarv
metabolite from inhaled n-butoxyethanol (Butylcellosolve). Acta
Pharmacol. Toxicol. 42: 354-356 (1978).
12. Kamerling, J. P, Duran, M., Bruinvis, L., Ketting, D., Wadman,
S. K., deGroot, C. J., and Hommes, F A. (2-Ethoxyethoxy)acetic
acid: an unusual compound found in the gas chromatographic
analysis of urinary organic acids. Clin. Chim. Acta 77: 397-405
(1977).
13. Cheever, K. L., Plotnick, H. B., Richards, D. E., and Weigel, W
W The metabolism and excretion of2-ethoxyethanol in the adult
male rat. Environ. Health Perspect. 57: 241-249 (1984).
14. DiVincenzo, G. D., Hamilton, M. L., Kaplan, C. J., Krasavage,
W J., and O'Donoghue, J. L. Studies on the respiratory uptake
and excretion and the skin absorption ofmethyl n-butyl ketone in
human and dogs. Toxicol. Appl. Pharmacol. 44: 593-604 (1978).
15. DiVincenzo, G. D., and Hamilton, M. L. Fate ofni-butanol in rats
after oral administration and its uptake by dogs after inhalation
or skin application. Toxicol. Appl. Pharmacol. 48: 317-325 (1979).